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[2135] Figure 1. EGD (A) showing esophageal ulcers, B showing inclusion bodies on histology,
repeat EGD (C) showing healed ulcers.

[2133] Figure 1. histopathology showing a basal-predominant, lymphocyte-rich, lichenoid
inflammatory infiltrate with associated dyskeratosis (apoptotic squamous cell, top left).
history of lichen planus or skin involvement in our male patient. Studies have shown that
polypharmacy (.3 medications) and the use of immunomodulatory agents is common
among patients with lichenoid esophagitis. Our patient took multiple asthma medications
including dupilumab, which may have contributed to his presentation. With scant available
literature, lichenoid esophagitis is a rare yet signiﬁcant etiology of dysphagia due to its
malignancy risk.
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Introduction: Pulmonary artery sling (PAS) is a rare anomaly created when the left pulmonary artery
originates from the posterior aspect of the right pulmonary artery and courses over from right to left,
posterior to the trachea or carina and anterior to the esophagus, to reach the hilum of the left lung. While
coursing, it can compress the trachea or the esophagus resulting in airway or esophageal obstruction.
Case Description/Methods: 43-year-old man with history of Down’s syndrome was evaluated for
esophageal dysphagia for solid food of 2-month duration. EGD was unrevealing except for mild distal
esophagitis. Mid and distal esophageal biopsies were negative for eosinophilic esophagitis. Barium esophagogram revealed extrinsic impression on the right side of esophagus just inferior to the aortic arch. CT
thorax revealed showed presence of left pulmonary artery (PAS) corresponding to the above-mentioned
extrinsic impression seen on esophagogram. Due to complexity and high mortality associated with the
required corrective surgery it was decided to manage this condition conservatively with dietary modiﬁcations.
Discussion: Vascular rings are congenital anomalies that can present with a variety of pulmonary
and gastroesophageal symptoms. PAS is a rare vascular anomaly ﬁrst described by Glaevecke and
Doehle in 1897. PAS can be associated with congenital cardiac anomalies like ASD, VSD or PDA or
airway anomalies like tracheal stenosis. Majority of patients are symptomatic and 2/3rd of patients
presents within their ﬁrst 2 months of life mainly with respiratory symptoms of stridor, respiratory
distress, cyanosis, wheezing, and/or pneumonia. Presentation in adulthood is extremely rare as only
one other case of adult-onset dysphagia caused by PAS has been reported in English literature in 1966
by Dumler. Arteriosclerotic dilatation of the anomalous pulmonary artery can account for late onset
of dysphagia in previously asymptomatic individuals. Corrective surgery is mainstay of treatment for
life-limiting symptoms after failure of conservative management.
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Introduction: Cytomegalovirus (CMV) esophagitis is the second most common gastrointestinal (GI) manifestation of CMV after colitis and typically occurs in immunocompromised
individuals. However, about a dozen of cases have been reported in immunocompetent individuals treated successfully with IV Ganciclovir or conservatively. Here, we report ﬁrst case of
CMV in immunocompetent adult treated successfully with oral valganciclovir.

[2134] Figure 1. Cartoon depiction of Pulmonary sling (A), Esophagram (B), CT (C, D) showing

Case Description/Methods: 59-year-old female with mild developmental delay otherwise in good
health, was evaluated for 1-year history of diﬃculty swallowing solid food. She denied having chest
pain, reﬂux symptoms, odynophagia, nausea, or vomiting. She was not on any medication and did
not consume tobacco or alcohol. EGD revealed multiple clean base ulcers in distal 6 cm of esophagus.
Biopsies revealed erosive esophagitis with granulation tissue along with positive immunostaining for
CMV inclusion bodies. She was started on oral valganciclovir 900 mg per day for 4 weeks. Her
dysphagia improved and EGD was repeated after completion of antiviral therapy which showed
resolution of esophagitis.
Discussion: CMV esophagitis presents with chest pain, dysphagia, odynophagia, anemia, GI
bleed, or weight loss. Symptomatic infection is rare in immunocompetent patient as only
handful of cases have been reported. EGD shows esophageal mucosal erosion, solitary or
multiple, shallow ulcers or diﬀuse esophagitis. Diagnosis is made on histology by discovering
cytomegalovirus inclusion bodies in the nucleus of the biopsy tissue obtained from base of the
ulcer. Majority of cases of CMV esophagitis in immunocompetent adults have been treated
with IV infusion of ganciclovir for at least 2-3 weeks, there is at least one report of successful
conservative management. While only few cases of successful treatment of upper GI CMV
with oral valganciclovir in immunocompetent infant have been reported, no such report
exists for adults. We describe ﬁrst case of CMV esophagitis successfully treated with Oral
valganciclovir.

S2136
Serendipitous Surveillance: A Case of Alpha-Fetoprotein-Producing Esophageal Adenocarcinoma
in a Patient With Prior Seminoma
Rochelle Wong, MD1, Christine Orr, MD, FRCPC2, Richard P. Cohen, MD3, Paul Miskovitz, MD3.
1
2
New York-Presbyterian/Weill Cornell Medical Center, New York, NY; Queen’s University, Kingston,
3
ON, Canada; Weill Cornell Medical College, New York, NY.
Introduction: Alpha-fetoprotein (AFP)-producing esophageal adenocarcinoma (EAC) is a rare
diagnosis. High AFP levels in adults are typically associated with primary hepatocellular carcinoma or
yolk sac tumors. Here we report an interesting case of an AFP-producing EAC found in an
asymptomatic patient with history of a germ cell tumor.
Case Description/Methods: A 67-year-old man with history of testicular seminoma status post
orchiectomy and radiation 15 years ago underwent serum tumor marker surveillance and was incidentally found to have elevated AFP to 154 ng/ml (normal , 8.0 ng/mL). He was asymptomatic,
not obese, and had no toxic habits. Basic bloodwork and imaging studies were unrevealing. Positron
emission tomography-computed tomography (PET-CT) showed abnormal uptake at the gastroesophageal junction (GEJ) with hypermetabolic GEJ lymph nodes. Upper endoscopy (EGD) showed a
GEJ circumferential mass from 38-42cm (Figure 1a), conﬁrmed on subsequent endoscopic ultrasound (EUS) (Figure 1b). Biopsies revealed high-grade esophageal adenocarcinoma (Figure 1c-d)
with loss of MLH1 and PMS2 staining (Figure 1e-f). He was started on neoadjuvant chemoradiation
with improvement in AFP.
Discussion: There are few case reports of AFP-producing EAC, which typically arise from Barrett’s
metaplasia. Due to insidious early symptoms, dearth of screening techniques, and high malignant
potential, AFP-producing tumors are often diagnosed at advanced stage with poor prognosis and
poor response to chemotherapy.1 Our patient’s diagnosis was incidental, with no Barrett’s or liver
disease; EAC is an uncommon secondary cancer following seminoma, and seminoma do not typically
express AFP.2 However, loss of MLH1 and PMS2 expression on histopathology suggests predisposing
mismatch repair deﬁciency. It is unclear if EAC has a yet-unidentiﬁed association with germ cell
tumors, and more studies are needed to identify at-risk populations to inform screening recommendations. When EAC is treated, AFP levels may be useful for monitoring for response and
recurrence.3
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aberrant pulmonary artery.
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